Abstract. Oxymatrine (OMT), which is a quinolizidine alkaloid extracted from the traditional Chinese herb Sophora flavescens Aiton, is often used to treat various inflammatory diseases. The present study aimed to investigate the protective effects of OMT against septic shock-induced myocardial injury in rats, and to determine the underlying mechanisms. In the present study, cecal ligation and puncture (CLP) was applied to generate a rat model of sepsis. The rats were randomly divided into six groups (n=8/group): Sham operation (CON) group, OMT control group, CLP model group, and CLP + OMT (high dose, 52 mg/kg; medium dose, 26 mg/kg; low dose, 13 mg/kg) groups. Cardiac function and histological alterations were analyzed by light microscopy and electron microscopy. Myocardial cell apoptosis was detected by terminal deoxynucleotidyl transferase dUTP nick end labeling assay. The mRNA and protein expression levels were examined by reverse transcription-polymerase chain reaction and western blotting, respectively. Furthermore, the levels of tumor necrosis factor (TNF)-α in the myocardial tissue were determined by radioimmunoassay. The results demonstrated that OMT exhibited anti-inflammatory properties, improved myocardial contractility and compliance, and significantly decreased pathological injury to rat myocardial ultrastructure. In addition, OMT significantly decreased heart rate and left ventricular end diastolic pressure, and increased mean arterial pressure, left intraventricular pressure change rate, and left ventricular end systolic pressure in rats following septic shock. Treatment with OMT attenuated the mRNA expression of lipopolysaccharide binding protein, cluster of differentiation 14, nuclear factor (NF)-κB (p65), TNF-α, p38-mitogen-activated protein kinase (MAPK) and caspase-3, and decreased the protein expression of NF-κB (p65), phosphorylated (p) NF-κB inhibitor-α, p-p38-MAPK caspase-3 and TNF-α in septic myocardial tissue. The present study concluded that OMT may offer substantial therapeutic potential for the treatment of septic shock-induced myocardial injury by inhibiting the TNF-α/p38-MAPK/caspase-3 signaling pathway.
Introduction
Sepsis and septic shock, which are caused by infection with gram-negative and gram-positive bacteria, fungi, viruses and parasites, have become increasingly important over the past few decades. Septic shock is a complex pathophysiological process, which is characterized by low blood pressure, systemic inflammatory reaction and multiple organ dysfunction. Patients suffering from sepsis utilize numerous medical resources, and the mortality rate is high and continuing to rise (1) . The heart is considered a main 'target organ' of sepsis-induced multiple organ dysfunction, and the occurrence of myocardial dysfunction further promotes the development and deterioration of sepsis, which significantly contributes to the mortality of patients with septic shock (2) . The pathogenesis of sepsis is very complex, and to date, studies regarding septic shock have concentrated on the generation of inflammatory mediators, including tumor necrosis factor (TNF)-α and interleukin-1β, and damage to the liver, lungs and kidneys (3) (4) (5) (6) . In addition, previous studies have demonstrated that the heart is a potential site for the generation of inflammatory mediators (7, 8) . Excessive production and release of proinflammatory mediators has an important role in the process of sepsis-induced myocardial dysfunction (SIMD) (9) . Excessive production of TNF-α, activation of the p38-mitogen-activated protein kinase (MAPK) pathway, and TNF-α-mediated apoptosis have been reported to have an important role in the progression of SIMD; however, the mechanism by which numerous toxic products are released due to the generation and release of inflammatory mediators and biological active substances has yet to be elucidated. Our previous study detected marked inflammatory damage in the myocardial tissue of a rat model of sepsis (10) . In addition, alterations to nuclear factor (NF)-κB activity are closely associated with the Oxymatrine protects against sepsis-induced myocardial injury via inhibition of the TNF-α/p38-MAPK/caspase-3 signaling pathway MINGHAO production and release of inflammatory mediators in sepsis. The TNF-α/p38-MAPK/caspase-3 pathway has also been shown to be involved in the pathophysiological process of myocardial depression and myocardial cell apoptosis (11) . These results suggested that inhibition of the expression of NF-κB, the production of TNF-α, and activation of the TNF-α/p38-MAPK/caspase-3 signaling pathway may have a positive role in the treatment of SIMD. Oxymatrine (OMT) is an alkaloid extracted from Sophora flavescens. OMT exhibits various biological activities, and its anti-inflammatory effects have been reported in experimental animal models and clinical studies (12, 13) . It has previously been demonstrated that OMT exerts inhibitory effects on Escherichia coli, Staphylococcus aureus, Salmonella typhimurium, Streptococcus agalactiae and Pasteurella multocida, and its effects are positively correlated with concentration (14) . Furthermore, it has been reported that OMT may reduce the generation of oleic acid in a rat model of acute lung injury by inhibiting the p38-MAPK signaling pathway and the expression of TNF-α (15) . In addition, by regulating the expression of lipopolysaccharide (LPS) recognition receptors [cluster of differentiation (CD)14 and scavenger receptor-A], OMT is able to reduce endotoxin-induced pathological lung damage in mice (16) . However, it remains unclear whether OMT is able to prevent myocardial apoptosis associated with infectious shock by inhibiting activation of the TNF-α/p38-MAPK/caspase-3 signaling pathway. The present study used a cecal ligation and puncture (CLP) rat model to examine the effects of OMT on inhibition of the TNF-α/p38-MAPK/caspase-3 signaling pathway in response to septic shock-induced cardiac muscle injury. (17) . The rats were maintained in light-and temperature-controlled conditions (12 h light/dark cycle; 22±2˚C) and were given ad libitum access to food and water. Briefly, rats were anesthetized with 40 mg/kg pentobarbital (2%; Sigma-Aldrich) by intraperitoneal injection. A 2-3 cm midventral abdominal incision was made to expose the intestines. The ileocecal valve was ligated with 3-0 silk and three perforations were made in the cecum using a 20-gauge needle. To ensure consistent cecal damage among the animals, the perforated cecum was squeezed until 50-80 µl feces extruded onto both surfaces, the bowel was reinserted into the abdomen and the incision was closed. In the sham group, the abdomen was opened to expose the intestines, and then closed. A single post-operative saline bolus was provided (30 ml/kg subcutaneous) for fluid support. Caudal artery blood pressure was monitored; once it had decreased to 2/3 basic blood pressure and <20 mmHg, the model was considered successful. Rats received the drugs via tail vein injection (volume, 5 ml/kg). In the sham and OMT control groups, rats received intravenous injection of normal saline and OMT (26 ml/kg), respectively, and the CLP group received normal saline (26 ml/kg). After treatment, the cecum was exposed under sterile conditions. The rats' tail artery pressure dropped to 2/3 of the baseline blood pressure and pulse pressure was reduced to <20 mmHg as a judgment of sepsis model standards.
Materials and methods

Chemicals
Cardiac function and histological analyses.
To examine the cardiac function of mice in response to sepsis, the right common carotid artery was used to determine heart rate (HR), mean arterial pressure (MAP), left intraventricular pressure change rate (LVdp/dt max ), left ventricular end systolic pressure (LVESP) and left ventricular end diastolic pressure (LVEDP) using cardiac catheterization. Rats were anesthetized with sodium pentobarbital (40 mg/kg, i.p.), and were then sacrificed by cervical dislocation. Subsequently, the heart was removed for histological analyses. Apical tissue blocks (~2 mm 3 ) were collected, fixed in 10% formalin, and embedded in paraffin. After staining with hematoxylin and eosin, pathological alterations to the myocardial tissue were observed under a light microscope (CHC-212; Olympus Corporation, Tokyo, Japan). Other myocardial tissues (~2 mm 3 ) were placed in 2% glutaraldehyde, and were sectioned as electron microscopy specimens, in order to observe ultrastructural changes.
RT-PCR analysis. Cardiac tissues (~100 mg) were collected and homogenized using a Polytron PT1200E (Kinematica, Shanghai, China). Total RNA was extracted using TRIzol ® reagent. The PCR reaction volume was 25 µl, and RT-PCR was conducted using the Promega One-Step RT-PCR kit (Promega Corporation, Madison, WI, USA). According to the protocol, 5 µl DEPC water, 5 µl AMV/TfI 5X buffer, 0.5 µl dNTP mixture, 1 µl 25 mM MgSO 4 , 0.5 µl Tf1 DNA polymerase, 0.5 µl AMV-RT, 12.5 µl Master Mix, 2.5 µl upstream primer (50 pmol), 2.5 µl downstream primer (50 pmol) and RNA (0.5-1 µg) were mixed in a microcentrifuge tube. RT-PCR was performed using GeneAmp 9700 thermal cycler (Applied Biosystems; Thermo Fisher Scientific, Inc., Waltham, MA, USA). First strand cDNA synthesis was conducted as follows: 1 cycle at 48˚C for 45 min for RT, 1 cycle at 94˚C for 2 min for AMV-RT inactivation and RNA/cDNA/primer denaturation. Second strand cDNA synthesis and PCR amplification were conducted as follows: 35 cycles at 94˚C for 30 sec for denaturation, annealing at the primer-specific temperatures for 1 min, 68˚C for 2 min for extension, and 1 cycle at 68˚C for 7 min for final extension. β-actin was used as an internal control. The primers and annealing temperatures used are listed in Table I . Primers were designed using Primer 5.0 software (Premier Biosoft, Palo Alto, CA, USA), and were synthesized by Baisheng Company (Beijing, China). The PCR products were analyzed by 2% agarose gel electrophoresis using a Gel Doc™ EZ system purchased from Bio-Rad Laboratories, Inc. (Hercules, CA, USA). The results were semi-quantified and expressed as relative optical density x surface area (mm 2 ). Relative mRNA expression levels were expressed as optical density normalized to β-actin.
Western blotting. Cardiac tissues (~100 mg) were collected and homogenized in radioimmunoprecipitation assay buffer (Biovision, Inc., Wuhan, China). Total protein concentration was measured using the BCA kit. Equal amounts of protein (40 µg) were separated by 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and were then transferred to 0.45 µm polyvinylidene difluoride membranes (KeHaoJia Company, Beijing, China). Blots were soaked in blocking buffer (5% non-fat milk) and were then incubated with the various primary antibodies (LBP, 1:200; anti-CD14, 1:200; NF-κB, 1:500; p-IκB-α, 1:200; p-p38-MAPK, 1:300; caspase-3, 1:300; β-actin, 1:400) at 4˚C overnight. After thorough washing with Tris-buffered saline containing 0.1% Tween 20, the membranes were incubated with horseradish peroxidase-conjugated anti-goat (cat. no. BA1060), anti-rabbit (cat. no. BA1054) and anti-mouse (cat. no. BA1051) secondary antibodies (1:10,000; Wuhan Boster Biological Technology Co., Ltd. (Wuhan, China), and immune complexes were visualized using an enhanced chemiluminescence detection system (Pierce Biotechnology, Inc., Rockford, IL, USA). The results were analyzed using a Gel Doc™ EZ system from Bio-Rad Laboratories, Inc. Expression levels were semi-quantified relative to the optical density of β-actin.
Electron microscopy. Apical sections of rat myocardial tissue (~2 mm 3 ) were collected and fixed in 2% glutaraldehyde for electron microscopy (H-600; Hitachi, Tokyo, Japan) in order to observe ultrastructural alterations to the myocardial tissue.
Radioimmunoassay. The levels of TNF-α in the myocardial tissue were determined by radioimmunoassay, according to the manufacturer's protocol. Myocardial tissue (100 mg) was mixed with a threefold volume of phosphate-buffered saline and was homogenized. Subsequently, the homogenate was centrifuged at 35,616 x g for 20 min at 4˚C, and the protein levels of TNF-α in the supernatant were quantified using the radioimmunoassay assay kit.
TUNEL assay. The TUNEL assay was conducted according to the manufacturer's protocol. Briefly, myocardial tissue was fixed in 4% paraformaldehyde for 1 h, and was processed for antigen retrieval with 0.1% Triton X-100 and 0.1% sodium F, forward; R, reverse; LBP, lipopolysaccharide binding protein; CD14, cluster of differentiation 14; NF-κB, nuclear factor-κB; TNF-α, tumor necrosis factor-α; p38-MAPK, p38-mitogen-activated protein kinase.
citrate for 2 min on ice. The tissue was subsequently incubated with a TUNEL reaction mixture containing terminal deoxynucleotidyl transferase in a humidified chamber for 1 h at 37˚C. Apoptosis of myocardial cells was characterized as reduced cell volume and visible brown particles within the nuclei. Myocardial cell apoptotic index (AI) was determined according to the following equation: AI = (total number of apoptotic cells/total number of cells) x 100%.
Statistical analysis. Data are presented as the mean ± standard error of the mean (n=3). Data were analyzed by one-way analysis of variance followed by Student-Newman-Keuls post-hoc test for multiple comparisons. Statistical analyses were conducted using SPSS 11.5 (SPSS, Inc., Chicago, IL, USA). P<0.05 was considered to indicate a statistically significant difference.
Results
Behavior and morphological alterations. Once the rats awoke from anesthesia, they started drinking and cleaning their fur. Rats in the CON and OMT groups exhibited a normal manner and appearance, as evidenced by a smooth and shiny coat and regular food intake. In addition, the rats in these groups did not appear dispirited or restless, and piloerection or chills were not observed. The abdominal organs also appeared normal. Rats in the CLP group gradually appeared listless, and exhibited reduced activity, food intake and responsiveness. In addition, the coat of the CLP rats appeared to have lost its luster. After 2-4 h, sickness gradually increased and the rats appeared slumped and restless, with increased piloerection, chills, diarrhea and eye secretions. After 9 h, their condition worsened. Following an intraperitoneal cesarean section, there was visible liquid turbidity in the abdominal cavity; and the cecum emitted a foul-smelling odor, alongside swelling, necrosis, adhesion, and jejunal bowel distension. These findings are consistent with the literature (18) , thus indicating that a rat model of sepsis was successfully generated. Rats in the CLP + OMT high and medium dose groups exhibited increased activity, and reduced dispiritedness, restlessness, piloerection and chills, as compared with the CLP group, following a laparotomy. In addition, there was no obvious liquid abnormality in the abdominal cavity, no cecal swelling, and no observation of gangrene and adhesion; however, improvement was not as obvious in the CLP + OMT low dose group.
Cardiac function assay. The CLP rat model was used to evaluate the effects of OMT on myocardial diastolic dysfunction, which is an important characteristic of septic shock in rats. As shown in Fig. 1 , there was no difference in the cardiac function parameters, including HR, MAP, LVESP, LVEDP, LVdp/dt max and -LVdp/dt max indices, between the OMT control group and the CON group. In the CLP group, each index was significantly altered compared with the CON group. HR was increased by 18%, MAP was reduced by 37%, LVESP was reduced by 27%, LVEDP was increased by 39%, LVdp/dt max was reduced by 38%, and -LVdp/dt max was reduced by 37%. Myocardial histological analysis. Myocardial histology appeared no different between the CON and OMT control groups. The endocardial membrane was complete, and edema and fibrous connective tissue hyperplasia were not detected. The myocardial stripes were clear and the nucleus was centered, with no vasodilation or inflammatory cell infiltration detected. Epicardial membrane integrity was intact, and was not covered with inflammatory exudate ( Fig. 2A  and B) . The myocardial tissue of the CLP group exhibited an extensively disordered subendocardial structure compared with the CON group. A wide range of inflammatory cells infiltrated the tissue, and large numbers of mononuclear cells, intermingled with a few lymphocytes and neutrophils were detected. In addition, telangiectasia and bleeding were observed (Fig. 2C) . The CLP group also displayed interstitial edema and fibroblast proliferation, and various degrees of cell necrosis and fibrosis. Myocardial tissue damage in the CLP + OMT low dose group was reduced to some degree; however, the myocardial structure remained slightly disorganized, with inflammatory cell infiltration, telangiectasia, bleeding, cell necrosis and fibrosis all detected (Fig. 2D) . Myocardial tissue damage in the CLP + OMT medium and high dose groups was markedly reduced, and normal basic cardiac structure was observed. Edema, degeneration and necrosis were notably reduced; however, a small amount of inflammatory cell infiltrate and a few exudative changes remained ( Fig. 2E and F) . These results indicate that OMT may reduce myocardial injury and exert protective effects on cardiac structure and function in rats with septic shock.
Myocardial ultramicrohistological analysis. The myocardial tissue, including myofilaments, sarcomeres, capillaries, mitochondria, sarcoplasmic reticulum and nuclei, was not altered in the OMT control group compared with the CON group, and all structures appeared normal ( Fig. 3A and B) . The myofilament and sarcomere arrangement was normal, and the capillaries opened well. In addition, mitochondrial structures were normal, and mitochondria exhibited complete membranes, dense ridges and clear matrix. The structure of the intercalated disks was continuous. Sarcoplasmic reticulum was smooth and continuous. Nuclear structure was clear, with slightly visible nuclear pyknosis and uniform chromatin. Conversely, the ultramicrohistological structure of the CLP myocardial tissue was markedly degraded. As shown in Fig. 3C , mitochondria appeared markedly swollen, resulting in damaged membranes and disordered cristae. Disordered myofilaments and sarcomeres subsequently dissolved, leading to the generation of vacuoles. The nuclei shrunk in size and the chromatin was marginated. The structure of the intercalated disks was not continuous, and dissolution was observed. However, the ultramicrohistological injuries of the myocardial tissue were markedly improved in the CLP + OMT groups (Fig. 3D-F) . The myocardial fibers were normally arranged, and the majority of mitochondria exhibited a complete structure with ordered dense ridges. Although the structure of the mitochondria cristae appeared vague, arrangement remained regular. In addition, mitochondrial swelling was reduced; however, in some cases mitochondrial damage was not yet fully recovered.
Effects of OMT on LBP, CD14, NF-κB (p65), TNF-α, p38-MAPK and caspase-3 mRNA expression.
The mRNA expression levels of LBP, CD14, NF-κB (p65), TNF-α, p38-MAPK and caspase-3 were similar in the myocardial tissue of the OMT control and CON groups. However, expression levels were significantly increased in the CLP group (P<0.05). Compared with the CLP group, the mRNA expression levels of LBP, CD14, NF-κB (p65), TNF-α, p38-MAPK and caspase-3 were markedly decreased in the CLP + OMT groups (P<0.05; Fig. 4) .
Effects of OMT on NF-κB (p65), p-IκB-α, p-p38-MAPK and caspase-3 protein expression.
Western blotting results indicated that NF-κB (p65), p-IκB-α, p-p38-MAPK and caspase-3 protein expression levels were similar in the myocardial tissue of the OMT control and CON groups. However, expression levels were significantly increased in the CLP group (P<0.05). Conversely, NF-κB (p65), p-IκB-α, p-p38-MAPK and caspase-3 protein expression levels were markedly decreased in the CLP + OMT groups compared with in the CLP group (P<0.05; Fig. 5 ).
Effects of OMT on TNF-α expression.
The results of a radioimmunoassay demonstrated that TNF-α levels were significantly increased in the CLP group compared with in the CON and OMT control groups (P<0.05). However, compared with the CLP group, the TNF-α levels were significantly decreased in the CLP + OMT groups (P<0.05) (Fig. 6A) .
Effects of OMT on myocardial cell apoptosis. No significant differences were detected in myocardial cell AI between the CON and OMT control groups. Compared with the CON group, myocardial AI was significantly increased in the CLP group (P<0.01). Conversely, myocardial AI was significantly reduced following treatment with various doses of OMT compared with in the CLP group (P<0.05) (Fig. 6B) .
Discussion
OMT, which is a type of alkaloid extracted from Sophora flavescens Ait., has previously been reported to exert positive pharmacological effects on regulation of the immune response, reduction of hypersensitive reactions, and inhibition of histamine release in vitro and in vivo (19) (20) (21) . Furthermore, OMT has been demonstrated to inhibit LPS-induced inflammation by downregulating Toll-like receptor (TLR)4/NF-κB in macrophages (22) . OMT also exerts protective effects on LPS-induced mastitis, an inflammatory reaction of the mammary gland, the anti-inflammatory mechanism of which has been shown to be associated with inhibition of the NF-κB and MAPK signaling pathways (23) . However, the pharmacological effects of OMT (24) demonstrated that OMT was able to ameliorate left ventricular hypertrophy and dysfunction in rats with heart failure. In addition, a combination of sodium ferulate and OMT has been reported to exert protective effects against CLP-induced lethal sepsis in mice (25) . Accordingly, the present study used the CLP-induced model of sepsis to investigate the anti-inflammatory effects of OMT, and aimed to determine its protective effects and possible underlying mechanisms on sepsis-induced cardiac injury. Sepsis is a complex pathophysiological process that is characterized by hypotension, hypoxia, metabolic acidosis, systemic inflammatory response and multiple organ dysfunction. The heart is considered a potential site for the generation of inflammatory mediators, and the generation and release of proinflammatory mediators, such as TNF-α, and activation of the p38-MAPK pathway has been reported to have an important role in sepsis-induced cell apoptosis and cardiac dysfunction (26) . A previous study confirmed that the three pathways: Janus kinase/signal transducers and activators of transcription, NF-κB and MAPK are important in the regulation of inflammatory signal transduction (27) . NF-κB is an important cell transcription factor associated with immune and inflammatory reactions, which has a core position in the convergence of these three intracellular signaling pathways (28) . In the resting state, NF-κB proteins combine with the IκB family proteins, and thus exist in the cytoplasm in their inactive form. Inactive NF-κB complex and active NF-κB are in dynamic equilibrium between the cytoplasm and nucleus. When gram-negative bacteria infect the body and die they release LPS. LPS is the main pathogenic gram-negative bacteria-associated molecular pattern, which is recognized by a series of receptors in the innate immune system, including LBP, CD14 and TLR4, resulting in activation of effector cells. LPS is known to first combine with LBP and CD14 in the circulating blood, thus forming the LPS-LBP-CD14 complex. This complex is then transported to the cell membrane, where it is anchored to the LPS receptor complex, and induces dimerization of TLR4 and two molecules of the extracellular adapter protein MD-2. The cytoplasmic region of TLR4 then interacts with the adaptor protein myeloid differentiation factor 88, inducing the activation of NF-κB-inducing kinase (NIK) (29) . NIK is a serine/threonine protein kinase, which can phosphorylate IκB kinase and induce its activation, consequently leading to IκB-α phosphorylation. Phosphorylation of IκB-α induces IκB and NF-κB dissociation, thus resulting in nuclear localization of NF-κB through the nuclear pore where it binds to corresponding DNA-specific sequences, so as to play its role in the regulation of gene transcription. NF-κB can bind to the fixed nucleotide sequence of subregions of numerous cytokines, and the promoters of inflammatory mediators, thus initiating gene expression of cytokines such as TNF-α (30). Upregulation of TNF-α eventually activates caspase-3 and induces myocyte apoptosis via the NF-κB signaling pathway.
The present study detected the mRNA expression levels of LBP, CD14, NF-κB (p65), TNF-α, p38-MAPK and caspase-3, and the protein expression levels of NF-κB (p65), p-IκB-α, p-p38 MAPK, caspase-3 and TNF-α in the myocardial tissue of rats with CLP-induced sepsis. The expression of all of these factors was significantly increased in the CLP group. In addition, HR and LVEDP were markedly increased, whereas These results suggested that cardiac structure and function were markedly damaged, and the underlying mechanism may be associated with activation of LBP and CD14 by toxins, such as LPS, on the myocardial cell membrane. Activation of the NF-κB (p65)/IκB-α signaling pathway may result in increased production of TNF-α and other inflammatory mediators, and activation of the p38-MAPK/caspase-3 pathway may induce myocardial cell apoptosis. Following intervention with various doses of OMT, the mRNA expression levels of LBP, CD14, NF-κB (p65) and TNF-α were significantly decreased in myocardial tissue compared with in the CLP group, thus indicating that OMT exerts marked inhibitory effects on the LBP, CD14 and NF-κB pathway in the myocardial tissue of rats with sepsis. The underlying mechanism of these effects may be associated with suppression of NF-κB (p65) expression and NIK activation, thereby inhibiting the expression of proinflammatory cytokines such as TNF-α. In addition, the mRNA expression levels of p38-MAPK and caspase-3 mRNA were significantly decreased, which was consistent with the decreased protein expression levels of p-p38-MAPK and caspase-3 detected in the myocardial tissue. Furthermore, following OMT treatment, cardiac function, myocardial tissue structure and ultrastructural injury were all markedly improved, and the myocardial AI was significantly reduced. These results indicated that OMT may increase myocardial contractility and compliance, correct increases in LVEDP caused by apoptosis of myocardial cells, and decrease preload, thus improving myocardial function. The underlying mechanisms of these effects may involve inhibition of TNF-α expression and reduced TNF-α-induced myocardial apoptosis, which is mediated by the p38-MAPK/caspase-3 pathway. The present study is the first, to the best of our knowledge, to demonstrate that sepsis-induced cardiac injuries are associated with the TNF-α/p38-MAPK/caspase-3 signaling pathway, and that OMT has the ability to suppress activation of the p38-MAPK/caspase-3 pathway. Therefore, OMT may be considered a potential therapeutic agent for the treatment of septic shock.
In conclusion, the present study provides valuable information regarding the mechanisms underlying the cardioprotective effects of OMT, thus providing a theoretical basis for further clinical studies focusing on the treatment of sepsis.
